Summit X LLC’s Teladoc Health TDOC Stock Holding History

Summit X LLC’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,205	Closed	-$203K	–	272
2021 Q2	$203K	Sell	1,205 -25	-2%	-$4.05K	0.05%	251
2021 Q1	$223K	Sell	1,230 -12	-1%	-$2.78K	0.06%	239
2020 Q4	$248K	Buy	+1,242	New	+$253K	0.07%	220
2020 Q2	$227K	Buy	+1,189	New	+$208K	0.08%	187

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Summit X LLC's TDOC Position: Q3 2021 in Review

Summit X LLC sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 1,205 shares — an estimated $203K sold.

Summit X LLC first reported a position in TDOC in Q2 2020 and held it in 4 quarters. The position peaked at $248K in Q4 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

Summit X LLC reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
Summit X LLC sold 1,205 Teladoc Health shares in Q3 2021, an estimated $203K.
Summit X LLC first reported a position in Teladoc Health in Q2 2020 and held it in 4 quarters.
Summit X LLC's Teladoc Health position peaked at $248K in Q4 2020.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Summit X LLC's 13F filing for Q3 2021, filed 19 Oct 2021.